COMMUNIQUÉS West-GlobeNewswire

Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants
29/07/2026
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, July 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“ [...]
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
29/07/2026
Room-temperature-stable and rapidly reconstituted, this first FDA-licensed product brings new options to emergency and remote settings Silver Spring, MD, July 29, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug [...]
SOUND Behavioral Health Launches Corporate Community Partner Program During 60th Anniversary Year
29/07/2026
SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- As SOUND Behavioral Health celebrates 60 years of serving the Puget Sound region, the organization has launched its new Corporate Community Partner Program, creating meaningful [...]
As New Research Shows Long Covid Affects 1 in 6 Patients, Apheresis Center Analysis Finds US Insurance Policies Are Driving Patients Abroad.
29/07/2026
New research doubles prior US Long Covid estimates, while US patients face insurance denials and a scarcity of domestic apheresis providers offering treatment is driving demand for international H.E.L.P. Apheresis [...]
CorVascular to Showcase DuplexABI™ Solution at SVU 2026 Annual Conference & Marketplace
29/07/2026
MINNEAPOLIS, July 29, 2026 (GLOBE NEWSWIRE) -- CorVascular today announced it will showcase its new DuplexABI™ solution at the Society for Vascular Ultrasound 2026 Annual Conference & Marketplace in National Harbor [...]
Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
29/07/2026
Ipsen appoints Catherine Bradley as independent Director to its Board of Directors PARIS, FRANCE, 29 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Catherine Bradley, CBE, as an [...]
Ipsen nomme Catherine Bradley en tant que nouvelle administratrice indépendante au sein de son Conseil d’administration
29/07/2026
Ipsen nomme Catherine Bradley, administratrice indépendante au sein de son Conseil d’administration PARIS, FRANCE, 29 JUILLET 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd'hui la cooptation de Catherine [...]
As Indiana's Nurse Shortage Grows, Jersey College and Lutheran Hospital Mark Five Years of Solving It Together
29/07/2026
A public event on July 30 celebrates the organizations’ efforts to reshape the local nursing workforce FORT WAYNE, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- Jersey College , the higher education institution dedicated to [...]
EssilorLuxottica: Publication of the 2026 Interim Financial Report
29/07/2026
Publication of the 2026 Interim Financial Report Paris, France (29 July 2026 – 6:00 pm) – The Board of Directors of EssilorLuxottica met on July 28, 2026 to approve the condensed consolidated interim financial [...]
EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2026
29/07/2026
Mise à disposition du Rapport financier semestriel 2026 Paris, France (29 juillet 2026 – 18h00) – Le Conseil d’administration d’EssilorLuxottica, qui s’est réuni le 28 juillet 2026, a arrêté les comptes consolidés [...]
First-half 2026 results
29/07/2026
Half-Year Results: strong improvement in operating performance Successful refinancing transactions Objectives confirmed Strong improvement in operating performance Revenue as at 30 June 2026 stood at €2,699m, up +4.6% [...]
Résultats semestriels 2026
29/07/2026
Résultats au 30 juin 2026 : forte progression de la performance opérationnelle Succès des opérations de refinancement Objectifs confirmés Forte progression de la performance opérationnelle Le chiffre d’affaires au 30 [...]
First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site
29/07/2026
Press Release Paris, 29th July 2026 €356.5 million Net Sales, down 13.5% year-on-year as reported and -11.8% on a comparative basis 1 As expected, including a negative €13 million impact from the planned discontinuation [...]
Les résultats du premier semestre 2026 confirment la résilience commerciale et opérationnelle dans un environnement de marché difficile - La transformation progresse selon le calendrier avec notamment la cession du site de Brindisi
29/07/2026
Communiqué de presse Paris, le 29 juillet 2026 Chiffre d’affaires de 356,5 millions d’euros, en baisse de 13,5% par rapport au S1 2025 et de -11,8% sur une base comparable 1 Comme prévu, incluant un impact négatif de 13 [...]
F6S Ranks Life Backup Plan 55th in Health and Wellness
29/07/2026
National ranking accompanies recognition from Pepperdine, TiE, ASCEND LA and two healthcare publications Aliso Viejo, CA, July 29, 2026 (GLOBE NEWSWIRE) -- F6S ranks Life Backup Plan® 55th on its, “ 100 Top Health [...]
New Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side Effects
29/07/2026
A new study using Clue's menstrual tracking data finds women vaccinated during the follicular phase were more likely to self-report side effects and had a longer time to subsequent infection than those vaccinated during [...]
BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets
29/07/2026
First wave of five directly operated clinics across Indonesia’s five major metropolitan areas with an initial investment of approximately US$1 million; standardized, machine-led clinic format designed for disciplined, [...]
Hyperion DeFi Schedules First Quarter Earnings Call for Wednesday, August 12 at 5:00 p.m. ET
29/07/2026
LAGUNA HILLS, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it [...]
The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
29/07/2026
--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Primary Endpoint, with [...]

Pages